Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPG 7909 + Radiation in Recurrent Low-Grade Lymphomas
NCT00185965Phase 2Completed
- Start
- Jul 2004
- Primary completion
- Mar 2010
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of agatolimod in B cell lymphoma, mycosis fungoides (MF). Started Jul 2004; status: completed.
02
Drugs
agatolimod
03
Conditions
B cell lymphomamycosis fungoides (MF)
Beyond the preview
Go deeper on NCT00185965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185965.